Katy Oswin is a seasoned professional in the biotech and pharma industry, boasting over 14 years of experience in technology solutions for growth and success. With expertise in eClinical platforms and AI-driven analytics, she collaborates with biotech, pharma, and CROs to optimize R&D and clinical trials. Katy holds an MPhil in Bioscience Enterprise from the University of Cambridge and a B.Sc (Hons) in Molecular Biotechnology and Pharmacology from the University of Sydney. Passionate about enhancing efficiency and accelerating drug development, she is dedicated to empowering organizations to improve patient outcomes through innovative solutions.

Read the full biography